COPE endorses GPP3

COPE endorses Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3[1].

Authors working in corporate–academic research collaborations must follow appropriate ethical standards. GPP3 describes such standards, and promotes the ethical practices established by organisations like COPE, ICMJE, and WMA. 

Amongst many recommendations, GPP3 places emphasis on the control that must be vested in authors; presents guidance about what documentation should be gathered through manuscript preparation and article publication; discusses publication planning and the role played by professional medical writers and the importance of authors retaining responsibility for content; suggests policies and procedures to support good publishing practice; and states that "all clinical trials should be reported". GPP3 updates and helps to clarify earlier guidance from GPP2 and GPP.

GPP3 is free to read at Annals of Internal Medicine and ISMPP's GPP3 website.

Reference
1. Battisti WP, Wager E, Baltzer L, Bridges D, Cairns A, Carswell CI, et al. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Ann Intern Med. Published online 11 August 2015 doi:10.7326/M15-0288